In children with autism, four weeks of intranasal oxytocin did not change the overall duration of fixations toward the face of a live interaction partner.
In plain wordsIn children with autism, oxytocin did not change how long they looked at the face of a live partner, compared with placebo.
- Peptide
- Oxytocin
- Outcome
- No significant changeDuration of fixations toward the face
- Study
n = 35
- Comparator
- Placebo
- Outcome group
- Social behavior and cognition · Mental health and mood
- Studied dose
- Dose not stated · intranasal · 4 weeksAs given in this study (human).
Source sentences
While the overall duration of fixations toward the face remained unchanged
1 context sentence(design, population, supporting numbers)
This double-blind, randomized, placebo-controlled trial examined the effects of four weeks of chronic intranasal oxytocin administration on gaze behavior and pupil dynamics during live dyadic interactions in school-aged children with autism (aged 8-12 years, 15 oxytocin, 20 placebo).